CanBas Company Ltd. is a biopharmaceutical company that develops anti-cancer drugs with fewer side effects. The Company's core technologies include drugs that target the G2 checkpoint and a screening system to find selective abrogators of the G2 checkpoint.
more
Refresh
Request Primer
No publications yet
No AI primers are available right now. Create one using Smartkarma AI.